LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Michael C. Snabes, MD, PhD, vice president of clinical development of BioSante Pharmaceuticals (NASDAQ: BPAX), will be presenting an overview of a key study in the LibiGel® (testosterone gel) development program at The Endocrine Society’s 90th Annual Meeting in San Francisco at the Moscone Center on Sunday, June 15, 2008. The Endocrine Society’s Annual Meeting (ENDO) is a leading venue for physicians and other clinicians who treat endocrine conditions, including female sexual dysfunction.
